Following national rollout, UK data provide early post-licensure evidence supporting maternal RSV vaccination as a real-world strategy to lower infant hospital admissions.
The U.S. Department of Health and Human Services has adopted a CDC advisory panel recommendation to remove thimerosal from all influenza vaccines, transitioning entirely to mercury-free, single-dose formulations.
New clinical recommendations detail updated vaccination and screening protocols to reduce infection and cancer risks in adults with inflammatory bowel disease, particularly those on immune-modifying therapies.
Researchers project that next-generation influenza vaccines could prevent up to 3 billion infections and be cost-effective in many countries with appropriate pricing strategies.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.